Congenica co-founder Professor Matt Hurles appointed as Director of the Wellcome Sanger Institute
Co-founder and Scientific Director at Congenica, Professor Matt Hurles, has today been appointed as Director of The Wellcome Trust Sanger Institute.
Congenica announces Early Access Program for its novel Precision Oncology Solution
Congenica launches early access program for its new CE-IVD Precision Oncology Solution
Congenica approved as supplier on Government G-Cloud 13 framework
Congenica is an approved supplier on UK Government G-Cloud 13 framework
Congenica awarded European contract to develop NGS analysis workflow in oncology
Congenica awarded a contract to develop standardised NGS workflows in oncology for a group of 7 Central European hospitals by the Medical University Graz
Congenica and FDB collaborate to incorporate PGx into Clinical Decision Support Systems
Congenica and FDB announce a collaboration agreement to develop the delivery of pharmacogenomics (PGx) results into point of care prescribing.
Congenica gives employees ‘cost of living’ bonus
Congenica employees receive one off bonus to help with increases in cost of living
Congenica announces partnership with Avesthagen
Congenica announces a partnership with Avesthagen, strengthenening Congenica’s presence in India
Collaborative development of novel Precision Oncology Solution
Congenica has selected the GenomOncology Precision Oncology Platform for the development of a novel ground-breaking CE-IVD Precision Oncology Solution.
Congenica appoints Robert Denison as CEO
Congenica announces the appointment of Robert Denison as Chief Executive Officer (CEO). He will also join the Board of the company.
Congenica wins Technology Company of the Year
Congenica wins Technology Company of the Year at the 2022 Cambridge Independent Science and Technology Awards
Congenica Appoints Dr. Tom Barber as Chief Scientific Officer
Congenica appoints Dr. Tom Barber as Chief Scientific Officer to lead the development and delivery of Congenica’s scientific and clinical vision
Congenica 为香港基因组计划提供全基因组测序三级数据分析
康剑尼科(Congenica)是一家数字健康公司，助力快速准确解读复杂基因组数据，为患者提供改变一生的答案。公司于今天宣布其将为香港首个大型基因组测序计划「香港基因组计划」提供全基因组测序三级数据分析。